Northwest Biotherapeutics, Inc. Common stock
NWBO
NWBO was delisted on the 16th of December, 2016.
10 hedge funds and large institutions have $453K invested in Northwest Biotherapeutics, Inc. Common stock in 2021 Q3 according to their latest regulatory filings, with 0 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 3 closing their positions.
0% more repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 1
21% less capital invested
Capital invested by funds: $577K → $453K (-$124K)
23% less funds holding
Funds holding: 13 → 10 (-3)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 3
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
MSAM
Moloney Securities Asset Management
Manchester,
Missouri
|
+$11K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
KA
Kovack Advisors
Ft. Lauderdale,
Florida
|
-$37K |
| 2 |
Fisher Asset Management
Camas,
Washington
|
-$21K |
| 3 |
SPIA
Steward Partners Investment Advisory
New York
|
-$10K |
| 4 |
CAPTRUST Financial Advisors
Raleigh,
North Carolina
|
-$1.91K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
MSAM
1
Moloney Securities Asset Management
Manchester,
Missouri
| $215K | +$11K | +8,600 | +5% |
|
|
OCG
2
Opus Capital Group
Cincinnati,
Ohio
| $58K | – | – | – |
|
|
WJWM
3
Williams Jones Wealth Management
New York
| $50K | – | – | – |
|
|
GWI
4
Grace & White Inc
Ny,
New York
| $32K | – | – | – |
|
|
AIP
5
Almanack Investment Partners
Wayne,
Pennsylvania
| $29K | – | – | – |
|
|
LDB
6
Lee, Danner & Bass
Nashville,
Tennessee
| $26K | – | – | – |
|
|
AA
7
AlphaMark Advisors
Ft. Wright,
Kentucky
| $18K | – | – | – |
|
|
GG
8
Gofen & Glossberg
Chicago,
Illinois
| $16K | – | – | – |
|
|
9
CAPTRUST Financial Advisors
Raleigh,
North Carolina
| $8K | -$1.91K | -1,500 | -19% |
|
|
AA
10
Ancora Advisors
Cleveland,
Ohio
| $1K | – | – | – |
|
|
KA
11
Kovack Advisors
Ft. Lauderdale,
Florida
| – | -$37K | -25,000 | Closed |
|
|
12
Fisher Asset Management
Camas,
Washington
| – | -$21K | -14,500 | Closed |
|
|
SPIA
13
Steward Partners Investment Advisory
New York
| – | -$10K | -7,000 | Closed |
|
NWBO Hedge Fund Activity: Q3 2021 in Review
10 of the 5,713 institutional investors tracked by Wall St. Rank reported a position in Northwest Biotherapeutics, Inc. Common stock (NWBO) for Q3 2021, worth a combined $453K — down 21% from $577K a quarter earlier.
Sellers outnumbered buyers: 3 funds closed out of NWBO and 0 opened new positions — a net loss of 3 holders — while 1 trimmed existing stakes and 1 added.
The largest buyer was Moloney Securities Asset Management, adding an estimated $11K. The largest seller was Kovack Advisors, exiting entirely with an estimated $37K sold.
- 10 institutional investors held Northwest Biotherapeutics, Inc. Common stock (NWBO) as of Q3 2021, down from 13 in Q2 2021.
- Funds reported $453K of Northwest Biotherapeutics, Inc. Common stock stock for Q3 2021, down 21% quarter-over-quarter.
- 0 funds opened new Northwest Biotherapeutics, Inc. Common stock positions in Q3 2021 and 3 closed out, a net change of -3 holders.
- The largest Northwest Biotherapeutics, Inc. Common stock buyer in Q3 2021 was Moloney Securities Asset Management, an estimated $11K added.
- The largest Northwest Biotherapeutics, Inc. Common stock seller in Q3 2021 was Kovack Advisors, an estimated $37K sold.
Based on aggregated 13F filings for Q3 2021.